Qual é o preço para Addex Therapeutics Ltd (ADXN)

O preço para Addex Therapeutics Ltd (ADXN) é $0.05124204

Qual é a capitalização de mercado para Addex Therapeutics Ltd (ADXN)

A capitalização de mercado para Addex Therapeutics Ltd (ADXN) é $7.78M

Addex Therapeutics Ltd (ADXN) Desdobramentos de Ações

Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.

Ano	Desdobramento	Multiplicador	Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.

Ano

Desdobramento

Multiplicador

Multiplicador cumulativo

Não há dados suficientes para as datas fornecidas.

Empresa	Número de desdobramentos de ações	Multiplicador cumulativo	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Empresa

Número de desdobramentos de ações

Multiplicador cumulativo

País